Automated External Defibrillators Market in North America Poised for Strong Growth

Shkira Ra 23 Sep, 2025 8 mins read 4

Automated External Defibrillators Market in North America Poised for Strong Growth

The automated external defibrillators market was valued at USD 938.8 million in 2024 and is expected to grow from USD 1,027.04 million in 2025 to reach USD 2,107.3 million by 2033, reflecting a CAGR of 9.4% during the forecast period. Automated external defibrillators (AEDs) are life-saving portable devices designed to treat sudden cardiac arrest, which occurs when the heart suddenly stops due to irregular rhythms. The combination of CPR and early defibrillation can save lives when applied within minutes of cardiac arrest.

Download Sample

Market Drivers

The growth of AEDs in North America is fueled by multiple factors. A key driver is the growing prevalence of cardiovascular diseases. Sedentary lifestyles, stressful work environments, and rising consumption of alcohol, tobacco, and drugs have increased the risk of heart-related disorders. According to the World Health Organization, 17.9 million people died from cardiovascular diseases in 2019, representing 32% of all deaths globally. In the U.S. alone, the Centers for Disease Control and Prevention reports 659,000 deaths annually from heart disease, with 805,000 heart attacks each year. Such high incidences highlight the urgent need for effective emergency devices like AEDs.

Another growth factor is the aging population. Research published in the Journal of Cardiovascular Development and Disease shows that age-related conditions like frailty, obesity, and diabetes increase cardiovascular risks. In the U.S., nearly half of all adults have cardiovascular disease, and the prevalence rises sharply among those over 60. This demographic trend directly boosts AED demand in hospitals, clinics, and public access areas.

Technological advancements further strengthen market expansion. Companies are introducing innovative solutions combining hardware and software to enhance pre-hospital care. For instance, Royal Philips launched its Tempus ALS remote monitoring and defibrillator solution, enabling real-time patient monitoring for EMS personnel. These innovations expand the scope of AED use beyond hospitals into homes, workplaces, and community settings.

Lastly, increasing investments from market players drive product development and accessibility. MicroPort Cardiac Rhythm Management raised USD 150 million in Series C financing to expand its AED product pipeline. Similarly, Philips allocated over EUR 1.9 billion to R&D in 2020, reflecting industry commitment to innovation.

Regional Insights

North America dominates the global AED market, driven by high cardiovascular disease prevalence and the presence of leading medical device companies. The region is expected to grow at a CAGR of 9.32% through 2030, with the U.S. leading adoption due to its large patient pool, advanced healthcare infrastructure, and supportive government initiatives. Public health campaigns and regulatory measures are also increasing awareness and accessibility of AEDs in public spaces such as schools, airports, and workplaces.

Europe follows as the second-largest market, forecasted to reach USD 603 million by 2030 at a CAGR of 9.7%, led by Germany and France. Meanwhile, Asia-Pacific emerges as the fastest-growing region, particularly in China and Japan, where governments are expanding AED availability in workplaces and public areas to combat sudden cardiac deaths.

Market Restraints

Despite promising growth, strict regulations present challenges for AED manufacturers. In Europe, the Medical Device Regulation (MDR) requires companies to meet stringent standards before approval, often delaying launches and raising costs. Similarly, regulatory hurdles in other regions affect product timelines and sometimes lead to recalls, slowing down adoption rates.

Market Opportunities

Growing investments and collaborations open new opportunities for AED manufacturers. Companies are expanding their R&D capabilities, while governments and healthcare providers are prioritizing broader access to defibrillators. The expansion of AED programs in workplaces, schools, and community centers represents a significant opportunity for market players to tap into public health initiatives.

Key Players

The North American AED market features several global leaders and regional innovators:

Asahi Kasei Corporation
Koninklijke Philips NV
Nihon Kohden Corporation
Schiller AG
Shenzhen Mindray Bio-Medical Electronics Co. Ltd
Stryker Corporation
CU Medical System Inc.
Mediana Co. Ltd.
BPL Medical Technologies Pvt. Ltd.
ViVest Medical

These players are actively investing in new product development, regulatory approvals, and strategic partnerships to strengthen their presence in North America and beyond.

Segment Insights

By Type: Semi-automated AEDs dominate the market with a CAGR of 9.32%, while fully automated AEDs are gaining traction with government-backed initiatives.
By End User: Hospitals and clinics hold the largest share, growing at a CAGR of 8.95%, supported by the high prevalence of in-hospital cardiac arrests, estimated at 290,000 annually in the U.S.. Public access settings and emergency medical services also represent fast-growing segments.
By Size & Application: Standard and pediatric AEDs are both in demand, with applications extending from manual and semi-automated to fully automated and wearable cardioverter defibrillators.

Recent Developments

In 2022, Asahi Kasei Medical acquired Bionova Scientific, LLC to strengthen its healthcare portfolio.
In 2022, Asahi Kasei Microdevices partnered with Silentium to enhance its technology base.

These strategic moves highlight ongoing consolidation and technological integration in the AED market.

About Us:

Straits Research is a global market intelligence and consulting company providing actionable insights and strategic guidance across industries. We specialize in delivering comprehensive market reports tailored for businesses, investors, and policymakers.